- Home
- MREO vs DIN Comparison
MREO vs DIN Comparison
Compare MREO & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- DIN
- Stock Information
- Founded
- MREO 2015
- DIN 1958
- Country
- MREO United Kingdom
- DIN United States
- Employees
- MREO N/A
- DIN N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- MREO Health Care
- DIN Consumer Discretionary
- Exchange
- MREO Nasdaq
- DIN Nasdaq
- Market Cap
- MREO 438.8M
- DIN 379.1M
- IPO Year
- MREO N/A
- DIN 1991
- Fundamental
- Price
- MREO $1.74
- DIN $21.39
- Analyst Decision
- MREO Strong Buy
- DIN Hold
- Analyst Count
- MREO 5
- DIN 9
- Target Price
- MREO $7.20
- DIN $26.57
- AVG Volume (30 Days)
- MREO 1.8M
- DIN 540.3K
- Earning Date
- MREO 08-12-2025
- DIN 08-06-2025
- Dividend Yield
- MREO N/A
- DIN 9.54%
- EPS Growth
- MREO N/A
- DIN N/A
- EPS
- MREO N/A
- DIN 2.99
- Revenue
- MREO $500,000.00
- DIN $845,368,000.00
- Revenue This Year
- MREO N/A
- DIN $8.62
- Revenue Next Year
- MREO $38.38
- DIN $1.82
- P/E Ratio
- MREO N/A
- DIN $7.16
- Revenue Growth
- MREO N/A
- DIN 2.92
- 52 Week Low
- MREO $1.47
- DIN $18.63
- 52 Week High
- MREO $5.02
- DIN $37.44
- Technical
- Relative Strength Index (RSI)
- MREO 44.98
- DIN 39.44
- Support Level
- MREO $1.64
- DIN $20.55
- Resistance Level
- MREO $1.78
- DIN $21.61
- Average True Range (ATR)
- MREO 0.09
- DIN 0.85
- MACD
- MREO 0.04
- DIN -0.00
- Stochastic Oscillator
- MREO 87.10
- DIN 43.20
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.